Patents by Inventor Peter F. Juby

Peter F. Juby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-ulcer agents
    Patent number: 4457932
    Abstract: Disclosed is a method of using certain substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one compounds, previously known as having antiallergy activity, for the treatment of peptic ulcer disease and other gastrointestinal diseases characterized by inflammation and necrosis.
    Type: Grant
    Filed: July 22, 1983
    Date of Patent: July 3, 1984
    Assignee: Bristol-Myers Company
    Inventors: Peter F. Juby, Thomas W. Hudyma, Douglas G. Colton
  • Pyrimidine-5-N-(1H-tetrazol-5-yl)-carboxamides
    Patent number: 4209623
    Abstract: A series of 1,6-dihydro-6-oxo-2-phenylpyrimidine-5-N-(1H-tetrazol-5-yl)carboxamides is provided for use as inhibitors of allergic reactions. The compounds show antiallergy activity by both oral and parenteral routes of administration.
    Type: Grant
    Filed: June 7, 1978
    Date of Patent: June 24, 1980
    Assignee: Bristol-Myers Company
    Inventor: Peter F. Juby
  • Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity
    Patent number: 4209620
    Abstract: A novel series of substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-ones is provided for use as inhibitors of allergic reactions. The compounds exhibit antiallergy activity by both oral and parenteral routes of administration.
    Type: Grant
    Filed: October 16, 1978
    Date of Patent: June 24, 1980
    Assignee: Bristol-Myers Company
    Inventor: Peter F. Juby
  • Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents
    Patent number: 4192944
    Abstract: A novel series of optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-5-yl)carboxamides is provided for use as inhibitors of allergic reactions. The compounds exhibit antiallergy activity by both oral and parenteral routes of administration.
    Type: Grant
    Filed: April 3, 1978
    Date of Patent: March 11, 1980
    Assignee: Bristol-Myers Company
    Inventor: Peter F. Juby
  • Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity
    Patent number: 4127720
    Abstract: A series of novel pyrimido[2,1-a]isoquinoline derivatives is provided for use as inhibitors of allergic reactions. The compounds exhibit antiallergy activity by both oral and parenteral routes of administration.
    Type: Grant
    Filed: September 21, 1977
    Date of Patent: November 28, 1978
    Assignee: Bristol-Myers Company
    Inventors: Peter F. Juby, Thomas W. Hudyma, Richard A. Partyka